201 related articles for article (PubMed ID: 18663431)
1. Baicalein attenuates intimal hyperplasia after rat carotid balloon injury through arresting cell-cycle progression and inhibiting ERK, Akt, and NF-kappaB activity in vascular smooth-muscle cells.
Peng CY; Pan SL; Huang YW; Guh JH; Chang YL; Teng CM
Naunyn Schmiedebergs Arch Pharmacol; 2008 Dec; 378(6):579-88. PubMed ID: 18663431
[TBL] [Abstract][Full Text] [Related]
2. The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signaling.
Razuvaev A; Henderson B; Girnita L; Larsson O; Axelson M; Hedin U; Roy J
J Vasc Surg; 2007 Jul; 46(1):108-15. PubMed ID: 17606126
[TBL] [Abstract][Full Text] [Related]
3. TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis.
Lin CF; Huang HL; Peng CY; Lee YC; Wang HP; Teng CM; Pan SL
Toxicol Appl Pharmacol; 2016 Aug; 305():194-202. PubMed ID: 27312871
[TBL] [Abstract][Full Text] [Related]
4. Tanshinone IIA inhibits smooth muscle proliferation and intimal hyperplasia in the rat carotid balloon-injured model through inhibition of MAPK signaling pathway.
Li X; Du JR; Yu Y; Bai B; Zheng XY
J Ethnopharmacol; 2010 May; 129(2):273-9. PubMed ID: 20363310
[TBL] [Abstract][Full Text] [Related]
5. Esculetin inhibits Ras-mediated cell proliferation and attenuates vascular restenosis following angioplasty in rats.
Pan SL; Huang YW; Guh JH; Chang YL; Peng CY; Teng CM
Biochem Pharmacol; 2003 Jun; 65(11):1897-905. PubMed ID: 12781342
[TBL] [Abstract][Full Text] [Related]
6. Naringenin inhibits angiotensin II-induced vascular smooth muscle cells proliferation and migration and decreases neointimal hyperplasia in balloon injured rat carotid arteries through suppressing oxidative stress.
Xu C; Chen J; Zhang J; Hu X; Zhou X; Lu Z; Jiang H
Biol Pharm Bull; 2013; 36(10):1549-55. PubMed ID: 23912743
[TBL] [Abstract][Full Text] [Related]
7. N-oleoylethanolamide suppresses intimal hyperplasia after balloon injury in rats through AMPK/PPARα pathway.
Zhao Y; Liu Y; Jing Z; Peng L; Jin P; Lin Y; Zhou Y; Yang L; Ren J; Xie Q; Jin X
Biochem Biophys Res Commun; 2018 Feb; 496(2):415-421. PubMed ID: 29305859
[TBL] [Abstract][Full Text] [Related]
8. Ursodeoxycholic acid inhibits intimal hyperplasia, vascular smooth muscle cell excessive proliferation, migration via blocking miR-21/PTEN/AKT/mTOR signaling pathway.
Huang R; Huang Y; Zeng G; Li M; Jin Y
Cell Cycle; 2020 Apr; 19(8):918-932. PubMed ID: 32202193
[TBL] [Abstract][Full Text] [Related]
9. N-acetylcysteine inhibited nuclear factor-kappaB expression and the intimal hyperplasia in rat carotid arterial injury.
Hayashi K; Takahata H; Kitagawa N; Kitange G; Kaminogo M; Shibata S
Neurol Res; 2001 Oct; 23(7):731-8. PubMed ID: 11680513
[TBL] [Abstract][Full Text] [Related]
10. Fludarabine prevents smooth muscle proliferation in vitro and neointimal hyperplasia in vivo through specific inhibition of STAT-1 activation.
Torella D; Curcio A; Gasparri C; Galuppo V; De Serio D; Surace FC; Cavaliere AL; Leone A; Coppola C; Ellison GM; Indolfi C
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2935-43. PubMed ID: 17293493
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of mutated IkappaBalpha inhibits vascular smooth muscle cell proliferation and intimal hyperplasia formation.
Zuckerbraun BS; McCloskey CA; Mahidhara RS; Kim PK; Taylor BS; Tzeng E
J Vasc Surg; 2003 Oct; 38(4):812-9. PubMed ID: 14560235
[TBL] [Abstract][Full Text] [Related]
12. Activation of NAD(P)H:quinone oxidoreductase 1 prevents arterial restenosis by suppressing vascular smooth muscle cell proliferation.
Kim SY; Jeoung NH; Oh CJ; Choi YK; Lee HJ; Kim HJ; Kim JY; Hwang JH; Tadi S; Yim YH; Lee KU; Park KG; Huh S; Min KN; Jeong KH; Park MG; Kwak TH; Kweon GR; Inukai K; Shong M; Lee IK
Circ Res; 2009 Apr; 104(7):842-50. PubMed ID: 19229058
[TBL] [Abstract][Full Text] [Related]
13. Blockade of vascular smooth muscle cell proliferation and intimal thickening after balloon injury by the sulfated oligosaccharide PI-88: phosphomannopentaose sulfate directly binds FGF-2, blocks cellular signaling, and inhibits proliferation.
Francis DJ; Parish CR; McGarry M; Santiago FS; Lowe HC; Brown KJ; Bingley JA; Hayward IP; Cowden WB; Campbell JH; Campbell GR; Chesterman CN; Khachigian LM
Circ Res; 2003 May; 92(8):e70-7. PubMed ID: 12690039
[TBL] [Abstract][Full Text] [Related]
14. Dioscin inhibits intimal hyperplasia in rat carotid artery balloon injury model through inhibition of the MAPK-FoxM1 pathway.
Fan T; He J; Yin Y; Wen K; Kang Y; Zhao H; Chen S; Li X
Eur J Pharmacol; 2019 Jul; 854():213-223. PubMed ID: 30940448
[TBL] [Abstract][Full Text] [Related]
15. Epothilone B inhibits neointimal formation after rat carotid injury through the regulation of cell cycle-related proteins.
Lim Y; Kim TJ; Jin YR; Kim DW; Kwon JS; Son JH; Jung JC; Avery MA; Son DJ; Hong JT; Yun YP
J Pharmacol Exp Ther; 2007 May; 321(2):648-55. PubMed ID: 17289837
[TBL] [Abstract][Full Text] [Related]
16. Hydrogen-rich saline attenuates vascular smooth muscle cell proliferation and neointimal hyperplasia by inhibiting reactive oxygen species production and inactivating the Ras-ERK1/2-MEK1/2 and Akt pathways.
Chen Y; Jiang J; Miao H; Chen X; Sun X; Li Y
Int J Mol Med; 2013 Mar; 31(3):597-606. PubMed ID: 23340693
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of vascular smooth muscle cell proliferation and neointimal formation in injured arteries by a novel, oral mitogen-activated protein kinase/extracellular signal-regulated kinase inhibitor.
Gennaro G; Ménard C; Michaud SE; Deblois D; Rivard A
Circulation; 2004 Nov; 110(21):3367-71. PubMed ID: 15520324
[TBL] [Abstract][Full Text] [Related]
18. The sphingosine kinase inhibitor N,N-dimethylsphingosine inhibits neointimal hyperplasia.
McDonald RA; Pyne S; Pyne NJ; Grant A; Wainwright CL; Wadsworth RM
Br J Pharmacol; 2010 Feb; 159(3):543-53. PubMed ID: 20015089
[TBL] [Abstract][Full Text] [Related]
19. Lercanidipine inhibits vascular smooth muscle cell proliferation and neointimal formation via reducing intracellular reactive oxygen species and inactivating Ras-ERK1/2 signaling.
Wu JR; Liou SF; Lin SW; Chai CY; Dai ZK; Liang JC; Chen IJ; Yeh JL
Pharmacol Res; 2009 Jan; 59(1):48-56. PubMed ID: 18973813
[TBL] [Abstract][Full Text] [Related]
20. New mechanism of rosiglitazone to reduce neointimal hyperplasia: activation of glycogen synthase kinase-3beta followed by inhibition of MMP-9.
Lee CS; Kwon YW; Yang HM; Kim SH; Kim TY; Hur J; Park KW; Cho HJ; Kang HJ; Park YB; Kim HS
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):472-9. PubMed ID: 19201691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
